Mylan, Sandoz Infringed Teva's MS Drug Patents, Judge Finds
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article